Last reviewed · How we verify
Acute exacerbation of chronic bronchitis
Approved treatments
- Amoxycillin · King George's Medical University
- Azo Gantanol · Pfizer
- Unasyn · Bristol-Myers Squibb
- Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Factive · Lg Chem Ltd
- Factive · Lg Chem Ltd
- Trimethoprim · Dr Reddys Labs Sa
- Ceftin · GSK
Ceftin works by inhibiting the bacterial enzyme responsible for cell wall synthesis, ultimately leading to bacterial cell death. - Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - Cefzil · Teva Pharmaceuticals USA
- Avelox · Novartis Pharmaceuticals
- PRULIFLOXACIN
Prulifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication. - Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Zymar · Allergan
- Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Vantin
- Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Cefditoren Pivoxyl · Vansen Pharma
- Noroxin
- Floxin
- Biaxin · Generic (originally Abbott/AbbVie)
Clarithromycin is a macrolide antimicrobial drug. - Suprax
Suprax works by inhibiting the bacterial enzyme 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, disrupting bacterial cell wall synthesis. - Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - CEFDITOREN
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
- Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute exacerbation of chronic bronchitis patent landscape — cliff calendar, originator estates, attackable patents
- Acute exacerbation of chronic bronchitis treatment landscape brief
- Acute exacerbation of chronic bronchitis treatment updates RSS
Frequently asked questions about Acute exacerbation of chronic bronchitis
What drugs treat Acute exacerbation of chronic bronchitis?
Tracked treatments include Amoxycillin, Azo Gantanol, Unasyn, Avelox, Factive, Trimethoprim, Ceftin, Amoxil.
What is the treatment for Acute exacerbation of chronic bronchitis?
Standard treatment for Acute exacerbation of chronic bronchitis includes Amoxycillin, Azo Gantanol, Unasyn, Avelox, Factive. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute exacerbation of chronic bronchitis patent cliff · Acute exacerbation of chronic bronchitis CI report
- Treatment: Amoxycillin · King George's Medical University
- Treatment: Azo Gantanol · Pfizer
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Avelox · Bayer AG
- Treatment: Factive · Lg Chem Ltd
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing